YU49316B - Novi intermedijari, njihova primena u sintezi n,n'-premoštenih bisindolilmaleimida i farmaceutske formulacije - Google Patents

Novi intermedijari, njihova primena u sintezi n,n'-premoštenih bisindolilmaleimida i farmaceutske formulacije

Info

Publication number
YU49316B
YU49316B YU61096A YU61096A YU49316B YU 49316 B YU49316 B YU 49316B YU 61096 A YU61096 A YU 61096A YU 61096 A YU61096 A YU 61096A YU 49316 B YU49316 B YU 49316B
Authority
YU
Yugoslavia
Prior art keywords
prepare
novel intermediates
pharmaceutical formulations
bridged bisindolylmaleimides
bisindolylmaleimides
Prior art date
Application number
YU61096A
Other languages
English (en)
Other versions
YU61096A (sh
Inventor
Margaret Mary Faul
Christine Ann Krumrich
Leonard Larry Winneroski Jr.
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21725638&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU49316(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU61096A publication Critical patent/YU61096A/sh
Publication of YU49316B publication Critical patent/YU49316B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Novi intermedijeri formule gde R1 predstavlja Br, I, ili O-tozil. Prijava sadrži još četiri nezavisna i devet zavisnih patentnih zahteva.
YU61096A 1995-11-20 1996-11-18 Novi intermedijari, njihova primena u sintezi n,n'-premoštenih bisindolilmaleimida i farmaceutske formulacije YU49316B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US734595P 1995-11-20 1995-11-20

Publications (2)

Publication Number Publication Date
YU61096A YU61096A (sh) 1999-03-04
YU49316B true YU49316B (sh) 2005-06-10

Family

ID=21725638

Family Applications (1)

Application Number Title Priority Date Filing Date
YU61096A YU49316B (sh) 1995-11-20 1996-11-18 Novi intermedijari, njihova primena u sintezi n,n'-premoštenih bisindolilmaleimida i farmaceutske formulacije

Country Status (31)

Country Link
EP (1) EP0776899B1 (sh)
JP (2) JP4100708B2 (sh)
KR (1) KR100342142B1 (sh)
CN (1) CN1066734C (sh)
AR (2) AR004718A1 (sh)
AT (1) ATE191219T1 (sh)
AU (1) AU701659B2 (sh)
BR (1) BR9611709A (sh)
CA (1) CA2237401C (sh)
CO (1) CO4750824A1 (sh)
CZ (1) CZ150398A3 (sh)
DE (1) DE69607443T2 (sh)
DK (1) DK0776899T3 (sh)
EA (1) EA000639B1 (sh)
ES (1) ES2145978T3 (sh)
GR (1) GR3033729T3 (sh)
HU (1) HU225716B1 (sh)
IL (1) IL124415A (sh)
MX (1) MX9803791A (sh)
MY (1) MY118946A (sh)
NO (1) NO310195B1 (sh)
NZ (1) NZ323282A (sh)
PE (1) PE17998A1 (sh)
PL (1) PL184728B1 (sh)
PT (1) PT776899E (sh)
TR (1) TR199800876T2 (sh)
TW (1) TW371661B (sh)
UA (1) UA56145C2 (sh)
WO (1) WO1997019080A1 (sh)
YU (1) YU49316B (sh)
ZA (1) ZA969645B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2245029A1 (en) 1998-03-13 1999-09-13 University Of British Columbia Granulatimide compounds as g2 checkpoint inhibitors
DE69911935T3 (de) * 1998-03-13 2008-02-07 The University Of British Columbia, Vancouver Granulatimide-derivate zur behandlung von krebs
US6127401A (en) * 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
US6300106B1 (en) 2000-11-22 2001-10-09 Ppg Industries Ohio, Inc. Method of preparing 3-[2-{(Methylsulfonyl)oxy}-ethoxy ]-4-(triphenylmethoxy)-1-butanol, methane sulfonate
EP2181999A1 (en) 2008-11-03 2010-05-05 Zentiva, A.S. Method of manufacturing ruboxistarin
WO2023192984A1 (en) * 2022-03-31 2023-10-05 4M Therapeutics Inc. N-desmethyl ruboxistaurin as kinase inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
CA2015996C (en) * 1989-05-05 2001-08-28 Hartmut Osswald Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
CN1050844C (zh) 1993-12-07 2000-03-29 伊莱利利公司 蛋白激酶ｃ抑制剂
US5559228A (en) * 1995-03-30 1996-09-24 Eli Lilly And Company Synthesis of bisindolylmaleimides

Also Published As

Publication number Publication date
CZ150398A3 (cs) 1998-12-16
GR3033729T3 (en) 2000-10-31
ATE191219T1 (de) 2000-04-15
DE69607443D1 (de) 2000-05-04
JP2000500496A (ja) 2000-01-18
ES2145978T3 (es) 2000-07-16
DK0776899T3 (da) 2000-07-10
HU225716B1 (en) 2007-07-30
ZA969645B (en) 1998-05-18
WO1997019080A1 (en) 1997-05-29
PL184728B1 (pl) 2002-12-31
KR19990067600A (ko) 1999-08-25
CA2237401C (en) 2003-10-21
AU7738896A (en) 1997-06-11
EA000639B1 (ru) 1999-12-29
PT776899E (pt) 2000-08-31
TR199800876T2 (xx) 1998-08-21
NO982105D0 (no) 1998-05-08
AU701659B2 (en) 1999-02-04
YU61096A (sh) 1999-03-04
BR9611709A (pt) 1999-02-23
IL124415A0 (en) 1998-12-06
EP0776899B1 (en) 2000-03-29
MX9803791A (es) 1998-09-30
KR100342142B1 (ko) 2002-08-22
HUP9901975A3 (en) 2000-01-28
CN1066734C (zh) 2001-06-06
AR004719A1 (es) 1999-03-10
IL124415A (en) 2003-11-23
PE17998A1 (es) 1998-04-20
EA199800368A1 (ru) 1998-12-24
JP4100708B2 (ja) 2008-06-11
DE69607443T2 (de) 2000-08-10
UA56145C2 (uk) 2003-05-15
CO4750824A1 (es) 1999-03-31
EP0776899A1 (en) 1997-06-04
CN1207740A (zh) 1999-02-10
AR004718A1 (es) 1999-03-10
MY118946A (en) 2005-02-28
JP2008138006A (ja) 2008-06-19
TW371661B (en) 1999-10-11
HUP9901975A2 (hu) 1999-11-29
PL326753A1 (en) 1998-10-26
CA2237401A1 (en) 1997-05-29
NO310195B1 (no) 2001-06-05
NO982105L (no) 1998-05-08
NZ323282A (en) 1999-01-28

Similar Documents

Publication Publication Date Title
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
TR199901305T2 (xx) Calpain-�nleyicileri olarak ketonbenzamidler
FI970067A0 (fi) 2-/(dihydro)pyratsolyyli-3'-oksimetyleeni/-anilidit tuholaistentorjunta-aineina ja fungisideina
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
SE9504661D0 (sv) New compounds
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
HUT76511A (en) Benzoyl derivatives, preparation and use thereot
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
NO980296D0 (no) Forbedrede terapeutiske midler
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
DE69819539D1 (de) Antithrombotische mittel
YU49316B (sh) Novi intermedijari, njihova primena u sintezi n,n'-premoštenih bisindolilmaleimida i farmaceutske formulacije
FI962481A (fi) 4-bentsoyyli-isokatsolit ja niiden käyttö herbisideinä
TR199701202T1 (xx) Yeni hidroksimik asit t�revleri.
DK0696278T3 (da) Herbicidtvirkende substituerede 1-phenyl- eller 1-pyridinylbenzotriazoler
SE9504662D0 (sv) New compounds
DE69828522D1 (de) Antithrombotische mittel
TR199900013T2 (xx) Yeni bile�ikler.
BR9808210A (pt) Befeniloxazolinas dissubstituìdas
FI934468A0 (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter
DE69614552T2 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
NO982151D0 (no) Hemoregulatoriske forbindelser
ATE268768T1 (de) Antithrombosemittel
FR2429207A1 (fr) (1-alkyl-5-nitro-2-imidazolyl)-vinyl-glyoxal-diacetals, lyl)-vinyl-glyoxal-ciacetals, leur obtention et leur utilisation